AzTrials
AzTrials

Language DelayNCT07529327

Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services

A study testing Comilia Group, Interaction Review Enhancement and Practical Support Enhancement in people with Language Delay and Substance Use Disorders, run by University of Oregon at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

The goal of this clinical trial is to test ways to improve early language development among young children of parents with substance use disorder (SUD). Children of parents with SUD are at increased risk for language delays, and early supports may help prevent long-term learning challenges. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Comilia Group, Interaction Review Enhancement and Practical Support Enhancement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
244 participants
Where
1 siteUnited States
Study dates
10 Mar 2026to 30 Nov 2029
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Have a:
  • Self-reported lifetime history of substance use disorder treatment and/or
  • active substance use in the past year
  • Be providing care for/parenting a child at least 10% of the time who is:
  • between the ages of 12-42 months
  • English/Spanish bilingual or monolingual in English or Spanish
Show all 14Show fewer
  • exposed to a third language once a week or less
  • not yet combining three or more words regularly
  • has less than 150 words in their expressive vocabulary
  • Be able to provide consent for their target child to participate, or have a legal guardian provide consent for the child to participate
  • Be able to speak and understand English and/or Spanish
  • Be willing to attend groups once a week for six weeks at a participating site/group time
  • If assigned additional services, willing to attend virtual meetings
  • Be 18 years of age or older

Who cannot join

  • -Only one caregiver per focal child can participate in the research study. Caregivers whose participating child already has another caregiver enrolled in the research study will not be eligible to participate.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Stephanie De Anda, PhD, CCC-SLP contact

541-346-8530

sdeanda@uoregon.edu

United States1 site, 1 recruiting
  • Prevention Science Institute

    Eugene, Oregon, 97403

    Stephanie De Anda, 541-346-8530, sdeanda@uoregon.edu

    Maya Casper, 775-848-8727, mcasper@uoregon.edu

    Recruiting

Other trials in United States

About this study

Official title: Evidence-based Intervention Enhancements to Reduce Language Delays and Disorders Among Children of Parents With Substance Use Disorders

The goal of this clinical trial is to test ways to improve early language development among young children of parents with substance use disorder (SUD). Children of parents with SUD are at increased risk for language delays, and early supports may help prevent long-term learning challenges. This study will examine whether adding additional supports to group-based parenting intervention improves child language outcomes compared to the group intervention alone.

Read the detailed description

The investigators will recruit and randomize a total of N=244 parent-child dyads to one of four treatment conditions using a 2x2 factorial design. Specifically, all participants will receive the group-based intervention from "Learn and Play Every Day" parent-implemented naturalistic communication intervention (PI-NCI) and will be randomized to receive the additional intervention modalities of (1) interaction review, (2) practical supports, (3) both, or (4) neither. The investigators will recruit participants from community agencies that provide support to adults with substance use disorders. Participants will be parents of a child between 18 and 42 months old and who have either a history of substance use disorder or active use within the last year (see Protection of Human Subjects for details). Interaction review and practical support intervention modalities will be conducted via telehealth. The investigators will randomize parents to intervention modality at the participant level through permuted blocks. The investigators will stratify randomization by the parent's primary language (English vs. Spanish) to ensure balance on this factor. Participant randomization will be masked to the interventionists delivering the group-based intervention. Interventionists delivering the interaction review and practical support modalities will not be aware of the presence or absence of the other intervention component. The investigators will collect information about parent responsivity and child language at baseline (T1, prior to receiving the intervention, immediately following the intervention (T2, 2 months), and at two follow-up assessments (T3, 4 months; T4, 6 months). Our primary analysis will compare pre-post gains in parent responsivity and child language comparisons between baseline and follow-up assessments. Parent-child interactions will be video recorded and then outcomes will be coded by trained staff, whereas child performance on the dynamic assessment task and parent performance on the functional cognitive-communication assessment will be scored in real-time by the data collector. Other self-reported measures such as demographics and substance use history will be collected through electronic survey software and stored on a secure server. The primary outcome of interest is parental responsivity, which is measured by the number of parental responses to intentional communicative acts from their child per minute. The secondary outcome of interest is child vocabulary (receptive and expressive). Additional outcomes include parenting knowledge and self-efficacy as well as secondary child outcomes such as rate of communication, sentence diversity, and language learning skill on the dynamic assessment task. Our primary interest (Aim 1a) is to compare the effectiveness of intervention modalities. The investigators will model changes in responsivity at two months post-baseline, as well as other outcomes, as a function of the intervention modalities and their interaction using generalized linear models adjusting for outcome values at baseline. Hypothesis tests will be conducted on the difference in outcome of each intervention modality from the mean of group means. Our overall judgment of the component will be primarily dependent on the component's effect on parental responsivity, but investigators will also take into account the effects on other parent and child outcomes. The investigators will conduct an intent-to-treat analysis, grouping participants by their treatment condition randomizations regardless of the fidelity of the intervention delivered. The effectiveness of an intervention can be undermined if it is difficult to administer or unacceptable to potential recipients. As a result, the investigators will collect feedback from parents, interventionists, and community partners through surveys and interviews. The questions posed will focus on evaluating the reach, acceptability, appropriateness, and fidelity of the intervention delivery (Aim 1b). The investigators will summarize and review the responses and use it to inform the interpretation of the results across Aim 1a and 1b. For example, if the interventions are found to be arduous to implement or unappealing to participants, this will be used to interpret the efficacy findings in context. In addition to assessing the efficacy and implementation of PI-NCI modalities, the investigators will assess differential treatment response and the mechanisms through which the intervention modalities function (Aim 2). The intervention modalities may not be equally effective across various psycho-social dimensions which may give opportunities for personalized treatment. Thus, investigators will assess the interactions (effect moderation) between the interventions and parental psychopathology, cognitive communicative impairment, social determinants of health on parental outcomes as well as prenatal exposure to substances on child outcomes. It is also important to understand how our interventions improve parental responsivity and other parent/child outcomes. Indeed, the investigators hypothesize that these interventions first improve parenting self-efficacy and knowledge, which in turn improves outcomes. Our analyses of mediators will use full information structural equation models to adjusted for baseline values and unbalanced covariates and the investigators will model moderators using similarly specified linear models. Our moderation analyses will assess the interaction terms between intervention components and our mediation analysis will examine the indirect effect of treatment modalities on outcomes through parenting efficacy and knowledge.

Being tested
Comilia Group, Interaction Review Enhancement, Practical Support Enhancement
Keywords
Naturalistic communication intervention, Parenting, Group based intervention, Vocabulary Acquisition
Medical subject headings
Language Development Disorders, Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Comilia GroupBehavioural

    Parents participate in six weekly 90-minute in-person groups led by a trained facilitator and offered in English or Spanish. Groups use modeled caregiver-child interaction videos and guided discussion to teach evidence-based communication strategies.

  • Interaction Review EnhancementBehavioural

    Parents receive three one-hour telehealth coaching sessions with a licensed speech-language pathologist to review caregiver-child interactions, practice communication strategies, and receive individualized feedback.

  • Practical Support EnhancementBehavioural

    Participants receive three one-hour telehealth sessions focused on identifying barriers to using the communication strategies introduced in the group sessions. Interventionists work with parents to develop structured supports (e.g., mindfulness tools, visual aids, tracking logs, timers) and set goals to address planning, attention, or memory challenges that may interfere with implementation.

Study groups in NCT07529327
Study groupRoleWhat they receive
Interaction Review Enhancement & Practical Supports EnhancementActive comparatorParticipants receive the Comilia Group intervention plus the interaction review sessions and practical support sessions.
Receives: Behavioral: Comilia Group; Behavioral: Interaction Review Enhancement; Behavioral: Practical Support Enhancement
Comilia Group OnlyActive comparatorParticipants receive the Comilia Group intervention only.
Receives: Behavioral: Comilia Group
Interaction Review EnhancementActive comparatorParticipants receive the Comilia Group intervention plus the Interaction Review Enhancement.
Receives: Behavioral: Comilia Group; Behavioral: Interaction Review Enhancement
Practical Support EnhancementActive comparatorParticipants receive the Comilia Group intervention plus the Practical Support Enhancement.
Receives: Behavioral: Comilia Group; Behavioral: Practical Support Enhancement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Parent responsivity

    Rate-based measure that describes parent responses to child intentional communication acts.

    Measured: Baseline, 2 months, 4 months and 6 months

Secondary outcomes (1)
  1. Receptive and expressive vocabulary

    Will be assessed using the MacArthur Bates Communicative Development Inventory: specifically the Dual Language Learners English-Spanish Inventories.

    Measured: Baseline, 2 months, 4 months and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2026
  2. Study start10 Mar 2026
  3. Primary completion30 Nov 2028 (estimated)
  4. Study completion30 Nov 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Model description
Randomized 2x2 factorial experiment
Masking
Single blind
Who is masked
Care provider
Enrolment
244 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07529327
Sponsor's protocol ID
STUDY00002032
Other IDs
R01DC022028
Status last verified
Oct 2026
First submitted
7 Apr 2026
Last updated
13 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All quantitative experimental data produced during the course of the project will be preserved and shared.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in